13F

TLSI TRISALUS LIFE SCIENCES INC

2026Q1 · CUSIP 89680M101 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
84
Δ holders QoQ
+20
Breadth percentile
Top 16%
Whale holders
39
Δ whales
+8
Inst. holding value
$83M
New positions
33
Closed positions
13
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2023Q4: Δ+10 · h=20 2024Q1: Δ+6 · h=26 2024Q2: Δ+2 · h=28 2024Q3: Δ+4 · h=32 2024Q4: Δ-4 · h=28 2025Q1: Δ+7 · h=35 2025Q2: Δ+13 · h=48 2025Q3: Δ+8 · h=56 2025Q4: Δ+8 · h=64 2026Q1: Δ+20 · h=84 2023Q4: holders=20 2024Q1: holders=26 2024Q2: holders=28 2024Q3: holders=32 2024Q4: holders=28 2025Q1: holders=35 2025Q2: holders=48 2025Q3: holders=56 2025Q4: holders=64 2026Q1: holders=84 -20 -10 +0 +10 +20 185489 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 16%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.42
EPS YoY
Revenue (TTM)
$0.0B
Revenue YoY
+39.6%
Quarterly Revenue & EPS (4Y)
2022-09-30: $4M 2023-03-31: $3M 2023-06-30: $5M 2023-09-30: $5M 2023-12-31: $6M 2024-03-31: $6M 2024-06-30: $7M 2024-09-30: $7M 2024-12-31: $8M 2025-03-31: $9M 2025-06-30: $11M 2025-09-30: $12M 2025-12-31: $13M 2026-03-31: $9M 2024-03-31: EPS -0.60 2024-06-30: EPS -0.21 2024-09-30: EPS -0.12 2024-12-31: EPS -0.38 2025-03-31: EPS -0.39 2025-06-30: EPS -0.27 2025-09-30: EPS -0.96 2025-12-31: EPS -0.22 2026-03-31: EPS 0.03 0M 7M 13M $M -1.06 -0.51 0.03 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)